Amgensp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-01-15
Share capital
22 374 500,00 PLN
Activity description

Amgen has been serving patients in Poland for 20 years. The company presents its mission and values as the foundation of its work supporting patients.

Registered address
ul. Puławska 145, 02-715 Warszawa, Poland
Website
amgen.plWebsite active
Social media
Electronic delivery address
AE:PL-56074-32987-UFUVG-32

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 145.07mMedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD 3.86mMedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 140.33mMedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 109.67mMedianUSD 541.73kAverageUSD 10.95m

Bank accounts

Registered as a VAT taxpayer on 2003-12-10. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Buildings and premises
PLN 1,259

Secured liabilities

Type
Registered pledge

Public aid

No public aid cases recorded in the last 10 years.

Tenders

982 tenders recorded as contractor: 133 national ($7,386,060) and 849 EU ($10,161,591,460).

SubjectAmount
Zakup i dostawy leków do programów lekowych, cytostatyków oraz leków stosowanych w ramach procedury rdtl
–
31/26 – Dostawa produktów leczniczych
–
Dostawa leków do chemioterapii i programów lekowych 2026-2028
–

Public sector contracts

Amgen is the contractor in 185 public sector contracts, worth PLN 84.15m in total. They were signed with 70 public buyers.

Public buyerValue
Uniwersytecki Szpital Dziecięcy w LubliniePLN 2,756
Uniwersytecki Szpital Dziecięcy w LubliniePLN 2,067
Szpital Uniwersytecki Nr 2 Im. Dr Jana Biziela w BydgoszczyPLN 2,672,434
Uniwersytecki Szpital Kliniczny Nr 4 w LubliniePLN 4,733
Wielkopolskie Centrum Pulmonologii I Torakochirurgii Im. Eugenii I Janusza ZeylandówPLN 1,154

Public procurement disputes (KIO)

Amgen has been a party to 1 case before the National Appeal Chamber (since 2019). It filed 1 appeal (1 discontinued).

DateCase no.RoleOther partyOutcome
Apr 15, 2019KIO 580/19AppellantZachodniopomorskie Centrum OnkologiiDiscontinued

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Agnieszka Jolanta Krawczyk – Attorney-in-fact (joint)
Magdalena Chrobot Osóbka – Attorney-in-fact (joint)
Katarzyna Ewa Czabańska – Attorney-in-fact (joint)
Gilles Marrache – Management Board Member
Krisztian Szabolcs Toka – Management Board Member

Manner of representation

The company is represented by two members of the management board acting jointly, or a member of the management board acting jointly with a commercial proxy.

Ownership

OwnerSharesShare valueStake
Amgen Worldwide Holdings B.v.
42,958$5,801,998.9295.9977%
Others
1,791$241,896.274.0023%

Beneficial owners

Person

Competitors

Name
Sanofisp. z o.o.
Novartis Polandsp. z o.o.
MSD Polska Dystrybucjasp. z o.o.
Bristol-Myers Squibb Polskasp. z o.o.
Astellas Pharmasp. z o.o.
Gilead Sciences Polandsp. z o.o.
Przedsiębiorstwo Zaopatrzenia Aptek Multi PharmeS.A.
Zentiva Polskasp. z o.o.
LubfarmS.A.
Magnapharm Polandsp. z o.o.

Change history

DateEvent
2025-11-30PKD change
2019-02-11Address change
2015-10-06PKD change
2014-02-18Share capital change
2013-02-25Address change

FAQ

Last updated: 2026-08-27